We create value in Life Science
MedCap develops leading niche companies in the life science industry
MedCap acquires and develops profitable, market-leading niche companies in the life science industry in Northern Europe that have the potential to grow internationally. The group conducts operations in two areas: MedTech and Specialty Pharma.
Year-end report 2021
Interim Report 1 2022
Annual general meeting 2022
The business is conducted in two areas, medical technology and specialist pharmaceuticals. Since 2001, MedCap has completed acquisitions, refinancing and sales.
Assistive technology for Cognition, Communication, Environmental Control and Alarm
Nordic, UK and Exports
Contract manufacturing of probiotics and nutrition supplements, and packaging solutions for pharmaceuticals
Carbon fiber components for MedTech applications